Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Investigation of ReNu Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis

Next Previous
Search
Trial Profile

An Investigation of ReNu Knee Injection: Monitoring the Response of Knee Function and Pain in Patients With Osteoarthritis

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 31 Aug 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Amniotic cell therapy-NuCel (Primary)
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Nutech Medical

    • Most Recent Events

    • 01 Jul 2021 Primary endpoint (KOOS Pain and Function Subscales Change from Baseline) has been met, as per results published in the Arthroscopy.
    • 01 Jul 2021 Primary endpoint (VAS Pain Scale Change from Baseline) has been met, as per results published in the Arthroscopy.
    • 01 Jul 2021 Results assessing efficacy and safety of amniotic suspension allograft (ASA) compared to hyaluronic acid (HA) and saline at up to 12 months of follow-up through the use of patient-reported outcomes, immunoglobulin levels, and anti-human leukocyte antigen (HLA) levels, published in the Arthroscopy.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top